Pipeline

Diverse Pipeline
  • Integrated, scalable, proprietary manufacturing platform
  • Unique mechanisms of action
  • Small production footprint to produce billions of doses of vaccines
  • Rapidly adapted to address new variants of concern
  • Long shelf life at 2- 8 °C
Pipeline
Target/MoA Discovery Pre-Clinical Phase 1/2 Phase 3 Partner
Oncology
JCXH-211
( srRNA )
IL-12
JCXH-211
( srRNA )
IL-12
  • Advanced Solid Tumors
  • GBM (IIT, US)
JCXH-212
( srRNA )
Cancer Vaccine
JCXH-212
( srRNA )
Cancer Vaccine
  • Advanced Solid Tumors (IIT, China)
TBD
( Undisclosed )
Antibodies
TBD
( Undisclosed )
Antibodies
  • Liver cancers
Infectious Diseases
JCXH-221
(Conventional mRNA)
Vaccine
JCXH-221
(Conventional mRNA)
Vaccine
  • COVID-19 (US)
JCXH-104
( Conventional mRNA )
Vaccine
JCXH-104
( Conventional mRNA )
Vaccine
  • COVID-19 (China)
JCXH-105
( srRNA )
Vaccine
JCXH-105
( srRNA )
Vaccine
  • Shingles
JCXH-107
( Conventional mRNA )
Vaccine
JCXH-107
( Conventional mRNA )
Vaccine
  • Influenza
JCXH-108
(Conventional mRNA)
Vaccine
JCXH-108
(Conventional mRNA)
Vaccine
  • RSV
Rare Diseases
JCXH-301
( Undisclosed )
Enzyme Replacement
JCXH-301
( Undisclosed )
Enzyme Replacement
  • Gaucher’s Disease
JCXH-H
(Undisclosed)
Enzyme Replacement
JCXH-H
(Undisclosed)
Enzyme Replacement
  • Undisclosed
Medical Cosmetology
JCXH-G
( Undisclosed )
Undisclosed
JCXH-G
( Undisclosed )
Undisclosed
  • Scar Prevention
  • Undisclosed